Genpact (G) SVP Sameer Dewan discloses share sale and tax withholding

Rhea-AI Filing Summary

Genpact Ltd senior vice president Sameer Dewan reported two transactions in Genpact common shares. On January 10, 2026, 9,780 shares were withheld at $48.24 per share to cover taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. After this withholding, Dewan beneficially owned 52,837 shares directly.

On January 13, 2026, Dewan sold 15,088 common shares at a weighted average price of $46.65 per share, with actual sale prices ranging from $46.40 to $47.05. These sales were made under a Rule 10b5-1 trading plan adopted on September 15, 2025. Following the sale, Dewan directly held 37,749 Genpact common shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dewan Sameer

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10175

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President

3. Date of Earliest Transaction (Month/Day/Year)
01/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/10/2026		F		9,780(1)	D	$48.24	52,837	D
Common Shares	01/13/2026		S		15,088(2)	D	$46.65(3)	37,749	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld for payment of taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3.

2. The sales transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.

3. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $46.40 to $47.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Sameer Dewan	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who reported this insider transaction for Genpact (G)?

The reporting person is Sameer Dewan, a Senior Vice President of Genpact Ltd, filing as an officer and not as a director or 10% owner.

How many Genpact (G) shares did Sameer Dewan sell and at what price?

On January 13, 2026, Sameer Dewan sold 15,088 common shares of Genpact at a weighted average price of $46.65 per share, with sale prices ranging from $46.40 to $47.05.

How many Genpact (G) shares does Sameer Dewan own after these transactions?

After the reported sale on January 13, 2026, Sameer Dewan beneficially owns 37,749 Genpact common shares directly.

What was the purpose of the 9,780 Genpact (G) shares reported on January 10, 2026?

The 9,780 shares on January 10, 2026 represent shares withheld to pay taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan, and are exempt under Rule 16b-3.

Were the Genpact (G) share sales by Sameer Dewan made under a Rule 10b5-1 plan?

Yes. The sales reported in this Form 4 were effected under a Rule 10b5-1 trading plan adopted by Sameer Dewan on September 15, 2025.

Are the reported Genpact (G) holdings of Sameer Dewan direct or indirect?

The Form 4 indicates the holdings are direct, with the ownership form shown as "D" and no nature of indirect beneficial ownership described.